DEF: Elevance Health Aims for Growth in 2025 After Navigating Dynamic 2024

Elevance Health's proxy statement outlines the company's 2024 performance, 2025 growth plans, and corporate governance practices.

Summary

• Elevance Health's proxy statement details the company's 2024 performance and outlines its growth plans for 2025.
• In 2024, Elevance Health's operating revenue reached $175.2 billion, a 3% increase from 2023, with an operating gain of $7.9 billion.
• The company returned $4.4 billion to shareholders through share repurchases and dividends and ended the year with approximately 46 million medical members.
• Elevance Health is focused on improving health outcomes, expanding healthcare services, and simplifying the healthcare experience.
• The company's Board of Directors recommends shareholders vote for the election of directors, the advisory vote on executive compensation, and the ratification of Ernst & Young LLP as auditors.
• The Board recommends voting against a shareholder proposal requesting a report on the effectiveness of diversity, equity, and inclusion efforts.
• The company's strategy framework includes investing in talent, transforming the business model, executing growth opportunities, and enabling care providers.
• Elevance Health is committed to corporate social responsibility, focusing on consumers, communities, associates, and the environment.
• The company's corporate governance policies emphasize board independence, accountability, and ethical standards.

Sentiment

Score: 7

Explanation: The document presents a balanced view of Elevance Health's performance, highlighting both achievements and challenges. The company's growth and commitment to corporate social responsibility are positive indicators, while the risks associated with forward-looking statements and the missed Adjusted Net Income target temper the overall sentiment.

Positives

• Elevance Health achieved a 3% increase in operating revenue in 2024.
• The company returned significant capital to shareholders through share repurchases and dividends.
• Elevance Health is a leader in NCQA Health Equity Accreditation Plus accreditations for Medicaid plans.
• The company has a strong focus on value-based care arrangements.
• Elevance Health has been recognized for its corporate impact and sustainability efforts.
• The company has a diverse Board of Directors and a commitment to workforce inclusion.
• Elevance Health has a fair pay workplace.

Negatives

• The document does not explicitly state any negatives.

Risks

• The document mentions that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially.
• These risks are discussed in Elevance Health's Form 10-K, including the sections captioned 'Forward-Looking Statements' and 'Risk Factors'.

Future Outlook

Elevance Health is well positioned to drive future growth for its shareholders through its multiple, complementary lines of business in a healthcare environment that continues to evolve at a rapid pace. The company is continuing to deepen the impact of Carelon and expand its deployment of innovative care models, positioning it to achieve sustainable growth over the long run.

Management Comments

• We look forward to welcoming you to Elevance Healths 2025 Annual Meeting on May 14, 2025, at 8 a.m. E.T. to review our 2024 performance and learn more about our growth plans for 2025.
• We value your voice and encourage you to vote promptly.
• We remain resolute in our goal to simplify the healthcare experience.
• Our purpose, passion and commitment to being a lifetime, trusted health partner for those we are privileged to serve will drive our success today and over the long term.

Industry Context

Elevance Health is addressing challenges in the healthcare ecosystem, including rising costs, administrative complexity, and disparities in access to care, by streamlining processes, reducing costs, and improving the overall experience for its members. The company is also expanding its healthcare services and capabilities through acquisitions and partnerships.

Comparison to Industry Standards

• The document mentions that the Committee has designed our executive compensation program to target total compensation (salary, target AIP award and the grant date fair value of equity awards) at the median for comparable positions in our two comparator groups.
• The first group consists of our direct industry peers: Centene Corporation, CVS Health Corporation, Humana Inc., The Cigna Group, UnitedHealth Group Incorporated.
• Due to the limited number of direct industry peers, the Committee also uses a second comparator group, which includes publicly-held companies in the Fortune 50 (excluding Elevance Health) with a similar amount of revenue (the General Industry Group).
• The General Industry Group includes: Alphabet Inc., Amazon.com, Inc., Apple Inc., Archer-Daniels-Midland Company, AT&T Inc., Bank of America Corporation, Berkshire Hathaway Inc., Cardinal Health, Inc., Cencora, Inc., Centene Corporation, Chevron Corporation, Citigroup Inc., Comcast Corporation, ConocoPhillips, Costco Wholesale Corporation, CVS Health Corporation, Dell Technologies Inc., Energy Transfer LP, Exxon Mobil Corporation, Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, FedEx Corporation, Ford Motor Company, General Motors Company, Humana Inc., Johnson & Johnson, JPMorgan Chase & Co., Lowes Companies, Inc., Marathon Petroleum Corporation, McKesson Corporation, Meta Platforms, Inc., Microsoft Corporation, PepsiCo, Inc., Pfizer Inc., Phillips 66, Target Corporation, Tesla, Inc., The Cigna Group, The Home Depot, Inc., The Kroger Co., The Walt Disney Company, United Parcel Service, Inc., UnitedHealth Group Incorporated, Valero Energy Corporation, Verizon Communications Inc., Walgreens Boots Alliance, Inc., Walmart Inc., Wells Fargo & Company.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the company's financial performance and capital allocation decisions.
• Members will benefit from the company's focus on improving health outcomes and simplifying the healthcare experience.
• Associates will be impacted by the company's commitment to workforce inclusion and fair pay.
• Communities will benefit from the company's corporate social responsibility initiatives.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Shareholders on May 14, 2025.
• The Board will review feedback from engagement meetings in its review of governance and compensation practices for the coming year.

Key Dates

Keywords

Elevance Health, proxy statement, corporate governance, executive compensation, shareholder, Board of Directors, financial performance, sustainability, diversity, equity, inclusion, healthcare